Gagnon Securities LLC Cuts Stake in Monsanto Company (NYSE:MON)
Gagnon Securities LLC lowered its position in Monsanto Company (NYSE:MON) by 1.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,242 shares of the basic materials company’s stock after selling 160 shares during the period. Gagnon Securities LLC’s holdings in Monsanto were worth $933,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in MON. First PREMIER Bank boosted its stake in Monsanto by 4.2% in the first quarter. First PREMIER Bank now owns 901 shares of the basic materials company’s stock valued at $102,000 after buying an additional 36 shares in the last quarter. Whitnell & Co. boosted its stake in Monsanto by 35.4% in the first quarter. Whitnell & Co. now owns 979 shares of the basic materials company’s stock valued at $111,000 after buying an additional 256 shares in the last quarter. Hartford Financial Management Inc. acquired a new stake in Monsanto during the first quarter valued at $113,000. Acrospire Investment Management LLC acquired a new stake in Monsanto during the first quarter valued at $113,000. Finally, JNBA Financial Advisors boosted its position in shares of Monsanto by 3.9% in the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock valued at $135,000 after buying an additional 45 shares during the period. 74.88% of the stock is owned by hedge funds and other institutional investors.
Monsanto Company (NYSE MON) remained flat at $117.86 during mid-day trading on Thursday. 1,307,376 shares of the company’s stock were exchanged. Monsanto Company has a 52-week low of $97.35 and a 52-week high of $118.97. The company’s 50-day moving average price is $117.53 and its 200-day moving average price is $114.70. The stock has a market cap of $51.78 billion, a P/E ratio of 25.57 and a beta of 1.07.
Monsanto (NYSE:MON) last issued its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.74 by $0.19. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The company had revenue of $4.23 billion during the quarter, compared to the consensus estimate of $4.18 billion. During the same period in the prior year, the company earned $2.17 EPS. Monsanto’s revenue was up 1.0% on a year-over-year basis. On average, equities research analysts anticipate that Monsanto Company will post $4.89 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Friday, July 7th were paid a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a yield of 1.83%. The ex-dividend date was Wednesday, July 5th. Monsanto’s dividend payout ratio is presently 46.75%.
COPYRIGHT VIOLATION WARNING: “Gagnon Securities LLC Cuts Stake in Monsanto Company (NYSE:MON)” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/08/03/gagnon-securities-llc-has-933000-position-in-monsanto-company-nysemon-updated-updated-updated.html.
Several brokerages recently commented on MON. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a research report on Thursday, June 29th. Barclays PLC increased their price objective on Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Thursday, June 29th. Royal Bank Of Canada reiterated a “sector perform” rating and set a $128.00 price objective (up from $120.00) on shares of Monsanto in a research note on Thursday, June 29th. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a research note on Tuesday, July 4th. Finally, Citigroup Inc. reiterated a “neutral” rating and issued a $126.00 price objective (up from $125.00) on shares of Monsanto in a research report on Monday, July 10th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have given a buy rating to the company. Monsanto currently has a consensus rating of “Hold” and a consensus target price of $123.15.
In other news, EVP Steven Mizell sold 11,300 shares of the company’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $118.57, for a total value of $1,339,841.00. Following the transaction, the executive vice president now owns 55,011 shares in the company, valued at approximately $6,522,654.27. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert T. Fraley sold 52,410 shares of the stock in a transaction that occurred on Monday, July 10th. The stock was sold at an average price of $117.95, for a total value of $6,181,759.50. The disclosure for this sale can be found here. Insiders have sold 74,470 shares of company stock valued at $8,791,281 over the last ninety days. Insiders own 0.79% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.